Hi,
I'm curious if anyone has ever discussed with your onc (or maybe even taken) a supplement called genistein, which is a natural TKI. Not sure if there's any potential in attacking CML with an EGFR-TKI in addition to our current targeted therapies:
>> The main known activity of genistein is tyrosine kinase inhibitor, mostly of epidermal growth factor receptor (EGFR).
Here is an old paper on the subject:
http://www.researchg...bitor_genistein
Thoughts?